![Profile Image](https://pbs.twimg.com/profile_images/1114240566001315840/wwBtyZu1_normal.png)
Teva Pharmaceuticals @TevaUSA
We need better regulatory guidance and pathways for complex generics, notes Teva’s Janet Vaughn at @AccessibleMeds #GRxBiosims. It’s critical that FDA foster the development of complex generics in order to improve patient access. https://t.co/MXulXO9BKN — PolitiTweet.org